RxDoctor Payments Data

Leah Neugebauer

Family · Bismarck, NDNPI 1326344615

Payments from drug & device makers

What this record shows

It is spread thinly across 22 manufacturers, the largest accounting for just 18.7%. Reporting peaked in 2022 at $1,357 and has fallen 54.1% since, to $622 in 2023. Among family clinicians in ND with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,324in general payments, 2019–2025

Across 52 payments — averaging $44.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$434
  • Seagen Inc.$349
  • Myriad Genetic Laboratories, Inc.$297
  • Astellas Pharma US Inc$219
  • E.r. Squibb & Sons, L.L.C.$213
  • AstraZeneca$201
  • plus $611 from 16 others

What the payments were for

  • Food & beverage$1,37559%
  • Education$94941%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,324 in reported general payments places this provider in the 90th percentile of 496 family providers in North Dakota.

See all family providers in North Dakota

Medicare billing

Part B allowed, 2024
$14,527
Medicare patients
40
Services billed
170

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LoperamideLoperamide Hcl11$270
Gabapentin26$254
Escitalopram Oxalate32$207
Duloxetine Hcl20$203
Rosuvastatin Calcium29$203
Warfarin Sodium32$201
Metoprolol Tartrate37$176
Oxybutynin Chloride ErOxybutynin Chloride26$163
Lisinopril30$133
Hydrochlorothiazide27$126
Trazodone Hcl21$109
Sertraline Hcl12$109
Metformin Hcl13$104
Cyclobenzaprine Hcl14$86
Pantoprazole Sodium12$86

Paid to pharmacies, not to this prescriber.

Other family in Bismarck

See the full list for North Dakota

Where these figures come from

Is this you, or does something look wrong? →